Global Plasmid Market was Valued at US$ 89.52 Million in 2018 and is Estimated to Reach US$ 447.68 Million by 2027, growing at a CAGR of 19.5% over the Forecast Period, Owing to Growing Awareness about Gene Therapy, says Absolute Markets Insights
PUNE, India, Feb. 5, 2020 /PRNewswire/ -- A plasmid is a small, circular piece of deoxyribonucleic acid (DNA), which is all the genetic material found in an organism's chromosomes and replicates independently of chromosomal DNA. Worldwide rising awareness levels about gene therapy across the globe in recent years is fostering the market growth. According to an article published by Human Gene Therapy, the adoption of gene therapy for chronic diseases, which include Alzheimer Disease is high around the world as compared to less severe diseases, namely, attention deficit hyperactivity disorder (ADHD). Gene therapy is a promising treatment option for various diseases such as inherited disorders, some types of cancer, and certain viral infections; and most commonly, gene therapy is an approach to treat the genetic disorders. Rising number of clinical trials related to gene therapy coupled with increasing funding for research and development activities is likely to nourish the global plasmid market during the forecast period. Surging waves of advanced genetic information have marked the advent of gene therapy revolution in the recent decade. The profound knowledge about gene therapy has accelerated the potential of human genetics and disease, therefore paving the way for gene therapy in pharmaceuticals in the 21(st) century.
https://mma.prnewswire.com/media/831667/Absolute_Market_Insights_Logo.jpg
Request a Sample@ https://www.absolutemarketsinsights.com/request_sample.php?id=363
Major participants in the global plasmid market are adopting growth strategies such as new product launches, mergers and acquisitions, collaborations, partnerships, geographical and operational expansions, among others in order to gain a competitive advantage. For instance, in July 2019, Mirus Bio LLC launched TransIT-VirusGEN SELECT Transfection Reagent, which was designed for the drug discovery pipeline in gene and cell therapy manufacturing process.
The detailed research study provides qualitative and quantitative analysis of global plasmid market. The market has been analyzed from demand as well as supply side perspective. The demand side analysis covers market revenue across regions and further across all the major countries. The supply side analysis covers the major market players and their regional and global presence and strategies. The geographical analysis emphasizes on each of the major countries across North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Enquiry Before Buying@ https://www.absolutemarketsinsights.com/enquiry_before_buying.php?id=363
Key Findings of the Report:
-- In terms of revenue, the global plasmid market is expected to reach US$
447.68 Mn by 2027
-- On the basis of general type plasmid, non-conjugative segment will
follow the conjugative segment over next nine years as non-conjugative
plasmids are incapable of initiating conjugation and they can only be
transferred through sexual conjugation with the assistance of
conjugative plasmids
-- By specific plasmid types, the F-plasmids segment dominated the market
in 2018 as F-plasmids can be inserted into chromosomal DNA and are
termed episomes. F plasmids enable the genetic exchange of material
among cells and control sexual functions of bacteria with a fertility
inhibition systems.
-- Based on application, the gene therapy segment accounted for the highest
market share in 2018 and is expected to continue its supremacy
throughout the forecast period as there has been a considerable growth
in gene therapy research in terms of volume, investments, and outcomes
over a recent few years
-- Europe represented the second largest plasmid market in 2018 due to high
demand for innovative therapies for chronic diseases and rising
prevalence of cancer among all age groups in the region. In addition,
highly developed healthcare infrastructure primarily in Germany,
Switzerland, the UK, and France is expected to drive the regional market
growth.
-- Some of the players operating in the global plasmid market are Aldevron,
GenScript, PlasmidFactory GmbH & Co. KG, VGXI, Inc., Oxford Genetics
Ltd., Applied StemCell, Altogen Biosystems, Cobra Biologics, Copernicus
Therapeutics, Inc., Takara Bio Inc., InvivoGen, Miltenyi Biotec,
MaxCyte, Inc., Mirus Bio LLC, MolMed S.p.A., GenePharma Co., Ltd.,
Polyplus Transfection, and other market participants
Request for Customization@ https://www.absolutemarketsinsights.com/request_for_customization.php?id=363
Global Plasmid Market:
By General Type Plasmid
-- Conjugative
-- Non-Conjugative
By Specific Plasmid Types
-- F-Plasmids
-- Resistance Plasmids
-- Virulence Plasmids
-- Degradative Plasmids
-- Col Plasmids
-- Cryptic Plasmids
By Application
-- Transfection
-- Gene Therapy
-- Recombinant DNA Technology
-- Others
By Region
-- North America
-- U.S.
-- Canada
-- Mexico
-- Europe
-- France
-- The UK
-- Spain
-- Germany
-- Italy
-- Nordic Countries
-- Denmark
-- Finland
-- Iceland
-- Sweden
-- Norway
-- Benelux Union
-- Belgium
-- The Netherlands
-- Luxemburg
-- Rest of Europe
-- Asia Pacific
-- China
-- Japan
-- India
-- New Zealand
-- Australia
-- South Korea
-- Southeast Asia
-- Indonesia
-- Thailand
-- Malaysia
-- Singapore
-- Rest of Southeast Asia
-- Rest of Asia Pacific
-- Middle East & Africa
-- Saudi Arabia
-- UAE
-- Egypt
-- Kuwait
-- South Africa
-- Rest of Middle East and Africa
-- Latin America
-- Brazil
-- Argentina
-- Rest of Latin America
Get Full Information of this premium report@ https://www.absolutemarketsinsights.com/reports/Plasmid-Market-2019-2027-363
About Us:
Absolute Markets Insights assists in providing accurate and latest trends related to consumer demand, consumer behavior, sales, and growth opportunities, for the better understanding of the market, thus helping in product designing, featuring, and demanding forecasts. Our experts provide you the end-products that can provide transparency, actionable data, cross-channel deployment program, performance, accurate testing capabilities and the ability to promote ongoing optimization.
From the in-depth analysis and segregation, we serve our clients to fulfill their immediate as well as ongoing research requirements. Minute analysis impact large decisions and thereby the source of business intelligence (BI) plays an important role, which keeps us upgraded with current and upcoming market scenarios.
Contact Us:
Company: Absolute Markets Insights
Email id: sales@absolutemarketsinsights.com
Phone: +91-740-024-2424
Contact Name: Shreyas Tanna
The Work Lab,
Model Colony, Shivajinagar, Pune, MH, 411016
Website: https://www.absolutemarketsinsights.com/
SOURCE Absolute Markets Insights
